Table 2.
Multivariate logistic regression model of factors associated with the use of any adjunctive measures within 28-day follow-up
| Variable | OR | 95% CI | p |
|---|---|---|---|
| Age | 0.99 | 0.98–1.00 | 0.001 |
| Comorbidity | |||
| Chronic respiratory impairment | 0.99 | 0.79–1.24 | 0.916 |
| Congestive heart failure | 1.20 | 0.89–1.62 | 0.241 |
| Chronic renal failure | 1.01 | 0.75–1.38 | 0.927 |
| Chronic liver failure | 0.65 | 0.41–1.03 | 0.069 |
| Immune incompetence | 1.27 | 1.02–1.57 | 0.030 |
| Diabetes | 1.28 | 1.03–1.57 | 0.027 |
| Clinical recognition at baseline | 1.66 | 1.38–2.00 | < 0.001 |
| Invasive mechanical ventilation (Ref. No.) | 1.86 | 1.37–2.52 | < 0.001 |
| PaO2/FiO2 (for each 10 mmHg) | 0.95 | 0.93–0.96 | < 0.001 |
| PIP | 1.03 | 1.02–1.04 | < 0.001 |
| PEEP | 1.15 | 1.12–1.19 | < 0.001 |
| High-income RW (vs Europe) | 0.40 | 0.32–0.50 | < 0.001 |
| Middle-income countries (vs Europe) | 0.78 | 0.62–0.98 | 0.030 |
Sample size, n = 2654
BMI body mass index, SOFA Sequential Organ Failure Assessment, PEEP positive end-expiratory pressure, PIP peak inspiratory pressure, RR respiratory rate, RW rest of the world